Cipla Share Price
₹1512.30
+21.40
(+1.44%)
as on
🔔 Product Launch Alert
Cipla launched Yurpeak (tirzepatide), a once-weekly injectable for obesity and type 2 diabetes in India, under a distribution agreement with Eli Lilly.
Cipla Stock Performance
as on December 11, 2025 at 4:01 pm IST
Day's Low
Day's High
₹1,492₹1,513.4
1.34%
Downside
0.07%
Upside
52 Week's Low
52 Week's High
₹1,335₹1,67311.72%
Downside
10.63%
Upside
Cipla share price movements today
- Previous Close
- ₹1,490.90
- Open
- ₹1,492.00
- Volume
- 6.06L
- Upper Circuit
- ₹1,639.90
- Lower Circuit
- ₹1,341.90
- Day's Low - High
- ₹1,492 - ₹1,513.4
- 52 Week Low - High
- ₹1,335 - ₹1,673
Cipla Historical Returns
- 1 Month Return
- -1.58 %
- 3 Month Return
- -4.48 %
- 1 Year Return
- + 2.53 %
- 3 Year Return
- + 35.93 %
- 5 Year Return
- + 97.25 %
Cipla Fundamentals
as on December 11, 2025 at 4:01 pm IST
Market Cap
₹1,20,430.61 Cr
Return on Equity (ROE)
17.17
PE Ratio (TTM)
22.13
Return on capital employed (ROCE)
21.4
Industry PE ratio
41.53
Beta (LTM)
0.83
P/B Ratio
3.63
Dividend Yield
1.11
PEG Ratio
1.85
Quarterly Earnings Growth YOY
3.6
EPS (TTM)
65.52
Sector
Pharmaceuticals
Book Value
386.25
Technical Analysis
Bearish
View Technical Analysis
Cipla Stock Valuation
as on December 11, 2025 at 4:01 pm IST
Cipla in the last 5 years
Lowest (18.11x)
March 19, 2020
Today (22.13x)
December 10, 2025
Industry (41.53x)
December 10, 2025
Highest (42.80x)
January 23, 2018
Today’s Price to Earnings Ratio: 22.13x
Cipla Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Cipla with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 1,20,430.61 | 19.45% | 0.51 | 5,291 | 27,547 | |
| HOLD | 1,67,099.20 | 14.57% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,28,413.97 | 37.35% | 0.66 | 1,911 | 11,516 | |
| BUY | 50,690.98 | -3.35% | 0.78 | 1,429 | 15,261 | |
| HOLD | 28,158.52 | -4.75% | 0.53 | 698 | 5,616 |
Analyst Recommendation on Cipla Stock
Based on 35 analysts
60.00%
Buy
20.00%
Hold
20.00%
Sell
Based on 35 analysts, 60% of analysts recommend a 'BUY' rating for Cipla. Average target price of ₹1680.09
Source: S&P Global Market Intelligence
Cipla Share Price Target
Get share price movements and forecasts by analysts on Cipla.
What analysts predicted
12.69%UPSIDE
Target Price
₹1680.09
Current Price
₹1512.3
Analyzed by
35 Analysts
High
₹1875
Target
₹1680.09
Low
₹1396
Cipla target price ₹1680.09, a slight upside of 12.69% compared to current price of ₹1512.3. According to 35 analysts rating.
Source: S&P Global Market Intelligence
Cipla Stock’s Investor Sentiment and Interest
Investment in Cipla Ltd Shares on INDmoney has dropped by -48.14% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Cipla Ltd Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Cipla Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Cipla Ltd Annual Profit & Loss
Figures in Rupees Crores
Cipla Ltd Cash Flow
Figures in Rupees Crores
Cipla Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Cipla Stock
Check out the Mutual Funds with significant holdings in Cipla.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 HDFC Flexi Cap Fund -Direct Plan - Growth Option | 3.42% | 21000000 | |
 Parag Parikh Flexi Cap Direct Growth | 1.21% | 10173460 | |
 SBI ELSS Tax Saver Fund Direct Growth | 2.89% | 6098542 | |
HDFC Focused Fund -Direct Plan - Growth Option | 3.5% | 6000000 | |
HDFC ELSS TaxSaver -Direct Plan - Growth Option | 4.8% | 5400000 |
Cipla Corporate Actions
View detailed summary of the earnings and dividend history of Cipla.
Cipla Ltd Earnings Results
Cipla Ltd’s net profit jumped 3.73% since last year same period to ₹1,351.17Cr in the Q2 2025-2026. On a quarterly growth basis, Cipla Ltd has generated 4.13% jump in its net profits since last 3-months.
Read More about Earnings ResultsCipla Ltd Dividends May,2025
In the quarter ending March 2025, Cipla Ltd has declared dividend of ₹3.00 per share on 13 May 2025 - translating a dividend yield of 1.07%.
Read More about Dividends
Cipla News & Key Events
Today's Timeline - 11 December
04:20 PM
-Cipla launches Yurpeak (tirzepatide) in India for obesity and type 2 diabetes, stock rises 1.5%.
Indices Featuring Cipla Stock
Check stock indices that include Cipla.
Insights on Cipla Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 1.22K Cr → 1.35K Cr (in ₹), with an average increase of 4.9% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, CIPLA stock has moved up by 2.5%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 7.01K Cr → 7.85K Cr (in ₹), with an average increase of 5.5% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 99.1%
- NO EFFECT
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 12.4% return, outperforming this stock by 9.9%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 29.13% of holdings in Sep 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 16.26% to 15.94% in Sep 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 20.40% to 20.17% in Sep 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 25.19% to 24.47% in Sep 2025 quarter
Cipla Stock Futures & Options Contracts
View the latest movement in Cipla Futures & Options, including strike prices, expiry dates, and percentage changes.
Cipla Options
Cipla Futures
About Cipla Ltd
Cipla's operations include manufacturing, marketing, and distribution of pharmaceuticals, biotechnology, and consumer healthcare products. Its top products include respiratory, anti-infectives, cardiovascular, and oncology drugs. Popular brands include Asthalin, Cipcal, Cifran, and Erythromycin. Cipla also manufactures nutraceuticals, herbal products, and over-the-counter medicines.
Revenue: ₹7,447.42Cr as on September 2025 (Q2 FY26)
Net Profit: ₹1,353.07Cr as on September 2025 (Q2 FY26)
Listing date: 03 Nov, 1994
Chairperson Name: Y K Hamied
| Organisation | Cipla Ltd |
| Industry | Pharmaceuticals |
| CEO | Y K Hamied |
| E-voting on shares | Click here to vote |
FAQs
What is Cipla share price today?
Cipla share price today stands at ₹1512.3 as on at the close of the market. Cipla share today touched a day high of ₹1513.4 and a low of ₹1492.
What is the 52 week high and 52 week low range for Cipla share?
Cipla touched a 52 week high of ₹1673 and a 52 week low of ₹1335. Cipla share price today i.e. is closed at ₹1512.3, which is -9.61% down from its 52 week high and 13.28% up from its 52 week low.
What is Cipla's market capitalisation today?
Cipla market capitalisation is ₹1,20,430.61 Cr as on .
How to buy Cipla shares?
To buy Cipla shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for CIPLA or Cipla Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Cipla shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Cipla trading volume today?
Cipla trading volume is 6.06L as on . This means that 6.06L shares of Cipla were bought and sold on the stock market during today's trading session.